Skip to content

Ketamine: all studies

Page 391 of 449: studies 3,901 to 3,910 of 4,490, newest first. Back to the ketamine overview

Research

IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?

Journal of Pakistan Psychiatric Society June 30, 2024 Nauman Ashraf 1 citation

Psychedelics, substances known to alter perception, mood, and consciousness, have been used across various cultures for centuries, often in religious ceremonies to facilitate spiritual experiences. Lysergic acid diethylamide (LSD) was used clinically from the 1950s until its ban in 1967. Recently, there has been a resurgence of interest in psychedelics for treating mental health disorders such...

Efficacy and Safety of Pharmacological Treatment in Patients with Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis.

Pharmaceuticals June 20, 2024 He Zhu, Bei Wen, Jijun Xu et al. 15 citations

Complex regional pain syndrome (CRPS) is a disabling condition that usually affects the extremities after trauma or surgery. At present, there is no FDA-approved pharmacological treatment for patients with CRPS. We performed this systematic review and meta-analysis to evaluate the efficacy and safety of pharmacological therapies and determine the best strategy for CRPS. We searched the...

DOI: 10.3390/ph17060811 (opens in new tab) Full text (opens in new tab) Pain relief Pharmacological treatment Chronic pain Pain management +6

Licit use of illicit drugs for treating depression: the pill and the process.

Journal of Clinical Investigation June 17, 2024 Alejandro Torrado Pacheco, Bita Moghaddam 3 citations

Psilocybin, MDMA, and ketamine have emerged as potentially effective treatments for rapid amelioration of the symptoms of mood and related psychiatric disorders. All clinical data collected so far with regard to psilocybin or MDMA, which have reported positive outcomes for treating depression, anxiety, posttraumatic stress disorder, and drug or alcohol use disorders, have involved...

DOI: 10.1172/jci180217 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Depression treatment Therapeutic environment Integrative medicine +1

Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm

Psychedelics June 14, 2024 N. Garel

Dr Nicolas Garel is an Assistant Professor in the Department of Psychiatry and Addictology at the University of Montreal and a junior investigator at the Research Center of the Centre Hospitalier de l'Université de Montréal. Dr Garel did his psychiatry residency at McGill University before completing the Clinician-Investigator Program and a Master's degree at McGill University, studying the...

Potencjał terapeutyczny wybranych substancji psychoaktywnych — przegląd najnowszych badań

Psychiatria June 5, 2024 Anna Stankiewicz, Jan Szewczyk, Julia Truszkowska et al. 1 citation

Drug therapies for many psychiatric conditions do not meet patients’ expectations. New agents are being sought to treat depression and anxiety disorders, among others. Scientific interest in psychoactive substances has increased over the past few decades. Recent studies provide evidence that psychedelics may find use in the treatment of a range of mental disorders. This paper describes new...

A Primer for Culturally Attuned Psychedelic Research

June 3, 2024 Terence Han Wei Ching preprint

Background: Systemic diversification of psychedelic research is needed, in light of interest in psychedelics for healing among Black, Indigenous, and Peoples of Color (BIPOC) and queer communities. Doing so also contributes to an inclusive evidence base, ethically meeting the anticipated demand for psychedelic treatments post-approval. Aims: Here, a primer for culturally attuned psychedelic...

Hallucinogens, dissociative drugs, and empathogens

Oxford Handbook of Addiction Medicine June 1, 2024

Abstract Chapter 16 of Addiction Medicine covers hallucinogens, dissociative drugs, and empathogens. Hallucinogens, also termed psychedelics, are a large and diverse group of substances, some of which occur in fungi and plants and some which are chemically synthesized. Some have psychostimulant properties as well. They include psilocybin, mescaline, dimethyltryptamine (DMT), ayahuasca, lysergic...

Fármacos enteógenos y la depresión resistente al tratamiento: Una revisión narrativa

Psicumex June 1, 2024 Andrea Herrera Solís, Jacqueline Cortés Morelos, Alejandra E. Ruiz Contreras et al.

Los enteógenos han surgido en la investigación clínica como un tratamiento alternativo para la Depresión Resistente al Tratamiento (DRT). Tienen efectos antidepresivos rápidos y duraderos, son ansiolíticos, y mitigan la ideación suicida. Además, inducen emociones positivas y provocan experiencias místicas o espirituales, atributos que pueden contribuir a su eficacia terapéutica, dada la...

Emergent Management of Status Epilepticus.

CONTINUUM Lifelong Learning in Neurology June 1, 2024 Clio Rubinos 6 citations

Status epilepticus is a neurologic emergency that can be life- threatening. The key to effective management is recognition and prompt initiation of treatment. Management of status epilepticus requires a patient-specific-approach framework, consisting of four axes: (1) semiology, (2) etiology, (3) EEG correlate, and (4) age. This article provides a comprehensive overview of status epilepticus,...

DOI: 10.1212/CON.0000000000001445 (opens in new tab) Full text (opens in new tab) Seizures Status epilepticus Emergency medicine Anticonvulsants +1

Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT

bioRxiv (Cold Spring Harbor Laboratory) May 31, 2024 Jakub Vohryzek, Selen Atasoy, Gustavo Deco et al. 8 citations preprint

Exploring the intricate relationship between brain's structure and function, and how this affects subjective experience is a fundamental pursuit in neuroscience. Psychedelic substances offer a unique insight into the influences of specific neurotransmitter systems on perception, cognition and consciousness. Specifically, their impact on brain function propagates across the structural...

DOI: 10.1101/2024.05.30.596410 (opens in new tab) Full text (opens in new tab) Connectome Consciousness Harmonics Perception +2